Clinical Excellence
Featured Stories
Evaluating Innovations in Middle Molecule Clearance
Heart, Kidney & Metabolic Care: A Strategic Imperative for Health Systems
SGLT2 Inhibitors Could Play Role in Slowing Kidney Disease Progression
This content is available for reuse with permission. If you are interested in reusing this content, please email newsroom@davita.com.
More in Clinical Excellence
-
American Heart Month is the Right Time to Learn About Kidney Health
Approximately one in two adults in the U.S. has hypertension (high blood pressure)—but only an estimated one in four have it under control. “High blood pressure is a symptomless ‘silent…
-
Sharing a Kidney—and a Life Together
When Sarah and Cliff Jones first met, they were both working in dialysis care—but they didn’t know how their professional experience in kidney care would play a significant role in their own…
-
Remote Care Connections Help Indiana Man Thrive While Receiving Home Hemodialysis
New technologies are helping to expand access and increase patient confidence to choose home dialysis more than ever before.
-
Home Free: A Story of Resilience
Lindsay O’Donnell is not alone in her journey with kidney disease. Thirty-seven million people in the U.S. share the same diagnosis. Many are fearful of what’s to come.
-
Community-Based Dialysis Providers Help Improve Vaccine Equity for America’s Most Vulnerable
In late March, COVID vaccines were allocated directly to dialysis providers to give to patients living with kidney failure, including ours. A campaign like this couldn’t have come fast enough for these 554,000 Americans.
